Mateusz Kaczmarek

Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?

Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?

Uranium Royalty Corp’s stock price has been on a tear, riding a wave of optimism in the nuclear energy sector. On October 15, UROY spiked intraday to about $4.87 per share, its highest level in a year Marketbeat. It closed that session up over 11% at roughly $4.75 Finviz – capping a stunning rally in recent months. Just a year ago UROY traded near $2.50; it has since doubled in value, now sitting ~85% higher than 12 months prior Finviz. Over 116% of those gains have come in 2025 alone as the uranium market heated up Finviz.
16 October 2025
Adaptimmune (ADAP) Sees Wild Stock Surge Amid Cash Crunch – Biotech Turnaround or Last Gasp?

Adaptimmune (ADAP) Sees Wild Stock Surge Amid Cash Crunch – Biotech Turnaround or Last Gasp?

Adaptimmune’s stock has been on a wild ride this year, with extreme price swings in recent weeks grabbing headlines. After languishing in penny-stock territory for months, ADAP suddenly caught fire in late September 2025. On September 19, shares opened at a mere $0.08 but skyrocketed 98% by day’s end to $0.16, then jumped another 30% after-hours to ~$0.20 ts2.tech. This stunning one-day move – without any company-specific catalyst – was accompanied by an enormous volume of 705+ million shares traded ts2.tech. Market observers noted Adaptimmune as one of the top gainers that session despite the lack of fundamental news nasdaq.com ts2.tech. The rally appeared driven by renewed investor interest and speculation, not new data – a Nasdaq report bluntly stated “no company-specific news was released on September 19” to explain the surge nasdaq.com. Instead, retail traders and momentum algorithms seemed to pile in, possibly in a short-squeeze frenzy or simple fear of missing out.
16 October 2025
··
Silver Hits All-Time High Above $53 and Gold Tops $4,200 – Why Prices Are Soaring

Silver Hits All-Time High Above $53 and Gold Tops $4,200 – Why Prices Are Soaring

Gold and silver prices are shattering records as anxious investors rush into safe-haven assets. This week, spot gold blew past the $4,200/oz milestone for the first time ever reuters.com, extending a remarkable rally that’s seen it gain over 60% so far this year reuters.com. Gold has now notched five consecutive sessions of gains, peaking around $4,243 on Thursday morning reuters.com. Its sister metal silver has been on an even more spectacular tear: spot silver hit $53.60/oz on Tuesday – a new all-time high, finally surpassing the long-standing 1980 and 2011 peaks reuters.com. Even after a modest dip to about $52.9 on profit-taking, silver remains up roughly 70–80% year-to-date ts2.tech fxstreet.com, making it one of 2025’s top-performing assets. By comparison, gold’s year-to-date gain is around 56–61% reuters.com reuters.com, itself a stunning rise that has captivated markets.
16 October 2025
·
Redwire (RDW) Shares Plummet on Shake-Up – Is a Takeoff Next?

Redwire (RDW) Shares Plummet on Shake-Up – Is a Takeoff Next?

Redwire closed about $9.40 on Oct 15, down ~1.5% on the day investing.com. The stock is volatile: it fell ~9.4% in one day and ~18.6% over a week after recent corporate news ts2.tech. Year-to-date, RDW is still down ~42% ts2.tech. Major catalysts include a new Oct 14 partnership with Red Cat to pair Redwire’s Stalker drone with Red Cat’s Black Widow quadcopter businesswire.com, a Sept 25 contract to supply solar arrays for Axiom Space’s station module, and the Aug launch of SpaceMD, Redwire’s new pharmaceutical subsidiary satellitetoday.com. Leadership changes also loomed: on Oct 7 Redwire announced two veteran directors joining its board and two departing ts2.tech, and CFO Jonathan Baliff will retire Nov. 30 ts2.tech. Analysts’ consensus 12-month target is ~$18–$19 ts2.tech public.com; Wall Street has mostly “Buy” ratings on RDW, though Bank of America recently kept an Underperform stance nasdaq.com.
15 October 2025
··
HOVR Stock Rockets as Horizon Aircraft Lands Pratt & Whitney Engine Partnership

HOVR Stock Rockets as Horizon Aircraft Lands Pratt & Whitney Engine Partnership

New Horizon Aircraft is focused on certifying and producing its Cavorite X7, a 7-seat hybrid-electric VTOL aircraft. The company envisions a first flight-worthy prototype within ~18 months and full production by the late-2020s. CEO Brandon Robinson said the successful May 2025 test flight “was already an incredible year for the technical team,” and now they are pushing toward full-scale design completion Verticalmag. Horizon notes it has the cash runway and partnerships to achieve these goals Sec Sec.
15 October 2025
···
Rocket Lab (RKLB) Stock Blasts Off: Japan Launch Deals and Analyst Upgrades Fuel 700% Rally

Rocket Lab (RKLB) Stock Blasts Off: Japan Launch Deals and Analyst Upgrades Fuel 700% Rally

Rocket Lab shares have been on a tear. As of mid-day Oct. 15, 2025, RKLB was trading around $72 per share Stockanalysis. The stock closed at about $68.03 on Oct. 14 Investing, extending a multi-week rally. Over the past year the shares are roughly 7× higher, and they regularly hit new highs – for example jumping ~7% to about $66 on Oct. 8 ts2.tech. Today’s price is well above the 50-, 100- and 200-day moving averages Benzinga and is within striking distance of its 52-week high Benzinga. In short, RKLB has nearly doubled year-to-date and significantly outperformed the Nasdaq, reflecting excitement over its growth story ts2.tech ts2.tech.
15 October 2025
···
Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge

Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge

Recursion’s stock showed wild swings in early October. On Oct 7, 2025 the shares fell about 5.4% to ~$5.23 amid a broad market slump nasdaq.com. The very next day the stock rebounded sharply, jumping roughly 16% to ~$6.08 ts2.tech. This put RXRX near the middle of its 52-week trading range ts2.tech. Trading volume on these moves was heavy, with tens of millions of shares changing hands as investors positioned for upcoming company news. By Oct 14, RXRX was around $5.89 stocktitan.net.
15 October 2025
···
Nokia Stock Surges on 5G Deals and Bullish Forecasts – What’s Next for NOK Investors?

Nokia Stock Surges on 5G Deals and Bullish Forecasts – What’s Next for NOK Investors?

Sources: Market quotes and technical data from Reuters reuters.com investing.com; Nokia financials and analyst data from MarketBeat marketbeat.com marketbeat.com; Nokia corporate news from company releases and RTTNews nasdaq.com nasdaq.com; industry developments from Reuters and TelecomTV reuters.com reuters.com telecomtv.com ts2.tech; forecasts and expert comments from Reuters and investing analysis reuters.com reuters.com investing.com.
15 October 2025
··
NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

Analysts note that SMR’s recent rally reflects both real progress and speculative fervor. On one hand, NuScale’s NRC approvals and partnerships set it up as an industry leader Finviz ts2.tech. In early October, NuScale shares even spiked +5% when Italy’s government moved to reintroduce nuclear power with “modular” reactors Nasdaq Nasdaq. On the other hand, NuScale still loses money and faces stiff competition Nasdaq Finviz. The Zacks report notes NuScale has underperformed peers recently Finviz. It warns that the energy market is competitive and that SMR’s valuation is stretched Finviz Finviz.
15 October 2025
···
Canadian Solar (CSIQ) Stock Skyrockets: Analyst Upgrade & Battery Boom Ignite Rally

Canadian Solar (CSIQ) Stock Skyrockets: Analyst Upgrade & Battery Boom Ignite Rally

Canadian Solar’s stock has surged sharply this week. On Oct 14 its share price hit a 52-week high of around $16.00 before closing at $15.72 Marketbeat. This spike was driven by two main headlines: Goldman Sachs unexpectedly raised its CSIQ price target on Oct 9, and news out of China about planned cuts to solar panel capacity. Indeed, Reuters reports that Chinese regulators may soon clamp down on excess PV manufacturing, which sent Chinese solar stocks soaring on Oct 14 Reuters. The ripple effect reached Canadian Solar too: research alerts note that CSIQ “surged by 10%” intraday on Oct 14 after these reports Gurufocus. Overall, the stock is about 28% higher year-to-date, beating the broad market.
15 October 2025
··
Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

On Oct. 15, Novo Nordisk and Seattle-based Omeros announced a definitive asset purchase and license agreement. Under the terms, Novo gains exclusive global rights to zaltenibart for all indications. Omeros will receive $340 million up front and near-term milestones, plus up to $2.1 billion total with development and sales milestones and tiered royalties Novonordisk. Reuters reported Novo would pay “up to $2.1 billion” for the experimental drug Reuters. The deal is structured as a licensing asset purchase, not a full acquisition, and is expected to close in Q4 2025 Marketscreener Novonordisk.
15 October 2025
···
Synchrony Financial Stock Surges on Blowout Q3 Earnings and $1B Buyback Plan

Synchrony Financial Stock Surges on Blowout Q3 Earnings and $1B Buyback Plan

Synchrony Financial’s stock has rallied on these strong fundamentals. After closing near $72.84 on Oct. 14, shares ticked up in early trading on Oct. 15 as investors digested the blowout results reuters.com marketbeat.com. The company’s Q3 beat was driven by tighter credit management and robust online spending, giving shareholders confidence. “Synchrony’s third-quarter performance was highlighted by a return to purchase volume growth… and continued strength in our credit performance,” said CEO Brian Doubles benzinga.com, echoing industry-wide trends of healthy consumer payments.
15 October 2025
··
Power Outage Paralyzes PATCO Trains: Thousands of Philadelphia Commuters Stranded

Power Outage Paralyzes PATCO Trains: Thousands of Philadelphia Commuters Stranded

Philadelphia’s regional PATCO Speedline sputtered to a halt at the worst possible time – the Wednesday morning commute. At about 8:30 a.m., PATCO announced all trains were suspended due to a power failure linked to PSE&G inquirer.com fox29.com. By 8:35 a.m. news outlets like NBC10 and FOX29 confirmed the shutdown, noting there was no timetable for service restoration inquirer.com fox29.com. PATCO said crews were on site but could not say when trains would resume inquirer.com.
15 October 2025
··
Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides

Humana Hit Hard: Judge Upholds Medicare Advantage Star Cut, Stock Slides

Humana sued CMS in July after its star rating unexpectedly plunged. The insurer argued that CMS unfairly flagged three interpreter calls as failures, causing a 4.5-to-3.5 star drop reuters.com healthcaredive.com. On Oct. 14, U.S. District Judge Reed O’Connor rejected Humana’s arguments reuters.com. He found that CMS had acted “in accordance with its guidelines” and did not act arbitrarily fiercehealthcare.com. In particular, the judge upheld CMS’s no-callbacks policy for those language-line test calls as lawful healthcaredive.com.
15 October 2025
·
Uber Stock Poised to Soar? Guggenheim’s $140 Price Target Explained

Uber Stock Poised to Soar? Guggenheim’s $140 Price Target Explained

On Oct. 15, Guggenheim’s Taylor Manley initiated coverage of Uber with a Buy and a $140 price target investing.com tipranks.com. Manley praised Uber’s “industry-leading network, technology, and brand equity,” noting that Uber’s global multi-platform network is now three times larger than any rival investing.com. With trailing revenue up ~18% year-over-year, Guggenheim sees Uber’s scale as a huge moat. The note emphasizes two growth engines:
15 October 2025
··
Plug Power (PLUG) Stock Rockets 170% on Analyst Hype and Major Hydrogen Deal

Plug Power (PLUG) Stock Rockets 170% on Analyst Hype and Major Hydrogen Deal

Plug Power’s stock has skyrocketed in early October 2025, driven largely by bullish analyst commentary and hydrogen project news ts2.tech marketbeat.com. On Oct. 3, H.C. Wainwright reiterated a Buy rating and doubled its 12-month target to $7, arguing that surging electricity costs and new energy policies make green hydrogen “more competitive” ts2.tech. Susquehanna followed by raising its target to $3.50 marketbeat.com. These calls ignited heavy trading – the stock spiked to $4.18 mid‑day Oct. 14 as short sellers covered positions marketbeat.com. MarketBeat notes one analyst calling PLUG a Strong Buy and several raising targets marketbeat.com, yet the average Street target remains far below current levels ts2.tech. In TS2’s analysis, Wall Street is “split” – bullish strategists cite improved fundamentals and policy tailwinds, while bears point out ongoing cash losses and dilution ts2.tech. Indeed, the average 12‑month price target implies potential downside, warning that the recent surge may be partly sentiment‑driven ts2.tech ts2.tech.
15 October 2025
·
Innoviz Stock Skyrockets on LiDAR Boom and Big Autonomous Driving Deals

Innoviz Stock Skyrockets on LiDAR Boom and Big Autonomous Driving Deals

Innoviz’s recent stock surge reflects these positive fundamentals. CEO Omer Keilaf emphasized in the Q2 report that “we generated more revenues than in all of 2024” in H1 and drove cash burn into low single digits ir.innoviz.tech. He noted Innoviz has begun shipping units from its new Fabrinet production line and is advancing its L3 and L4 programs. Keilaf also highlighted the InnovizSMART product, calling it “built on the same technological foundation as [our] automotive solutions” for smart infrastructure ts2.tech. These comments underscore that Innoviz is not only growing sales but also diversifying into security, traffic and robotics markets.
15 October 2025
··
1 … 110 111 112 113 114 … 173
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 TACTICAL BUY

dLocal

NASDAQ: DLO 88 / 100
#5 BUY THE RESET

Tapestry

NYSE: TPR 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.